About the Company
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TECH News
Director Roeland Nusse Sells 10,400 Shares of Bio-Techne Corp (TECH)
Director Roeland Nusse has sold 10,400 shares of Bio-Techne Corp (NASDAQ:TECH) on March 7, 2024, according to a recent SEC filing.
Bio-Techne and Qiagen had the biggest increase in short interest levels last month - Baird
Since the end of January, short interest levels increased, reaching 38% for Bio-Techne Corp. (TECH) and 23% for Qiagen N.V. (QGEN). Bio-Techne (TECH) saw the largest increase among the life sciences ...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn ...
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, ...
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
From 2020 to 2023, Bio-Techne experienced a growth in earnings per share, with an increase from $1.23 to $1.96. This positive ...
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as ...
High Performance Capillary Electrophoresis Instrument Market: Unveiling Innovative Solutions for Advanced Biomolecular Analysis
The High Performance Capillary Electrophoresis Instrument Market is a rapidly evolving industry that caters to a wide range of applications across various sectors, including pharmaceutical, ...
America's Greatest Workplaces for Job Starters 2024 - Mid Size Companies
Getting a career started is never easy. First-day stumbling blocks can give way to larger questions about choosing the right ...
Analyze Geron Corp. (NASDAQ: GERN) With This Review Before Investing
Geron Corp. (NASDAQ:GERN) traded at $1.96 at close of the session on Friday, February 23, made a downward move of -0.51% on its previous day’s price. Looking at the stock we see that its previous ...
Buy Rating Affirmed for Exact Sciences Amid Market Expansion and Product Advancement Prospects
Begin your TipRanks Premium journey today. Exact Sciences (EXAS) Company Description: Founded in 1995, Wisconsin-based Exact Sciences Corp. is a molecular diagnostics company, which focuses on the ...
Overview of the Cell Therapy Technologies Market
The Cell Therapy Technologies Market encompasses tools, equipment, and processes essential for the development, manufacturing, and delivery of cell-based therapies. With the rise of regenerative ...
Charles River Labs stock hits 52-week high
Charles River Laboratories (CRL) shares hit a 52-week high on Friday in the wake of last month's better-than-expected 2024 guidance. Read more here.
Loading the latest forecasts...